Back to the Future: Rethinking the Great Potential of lncRNA(S) for Optimizing Chemotherapeutic Response in Ovarian Cancer

Ovarian cancer (OC) is one of the most fatal cancers in women worldwide. Currently, platinum- and taxane-based chemotherapy is the mainstay for the treatment of OC. Yet, the emergence of chemoresistance results in therapeutic failure and significant relapse despite a consistent rate of primary respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsayed, Abdelrahman M., Amero, Paola, Salama, Salama A., Abdelaziz, Abdelaziz H., Lopez-Berestein, Gabriel, Rodriguez-Aguayo, Cristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564391/
https://www.ncbi.nlm.nih.gov/pubmed/32854207
http://dx.doi.org/10.3390/cancers12092406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564391/
https://www.ncbi.nlm.nih.gov/pubmed/32854207
http://dx.doi.org/10.3390/cancers12092406

Ejemplares similares